Discontinuation report ELOXATIN
| Report ID | 57608 |
| Drug Identification Number | 02296284 |
| Brand name | ELOXATIN |
| Common or Proper name | Eloxatin Solution 50mg/10ml |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | OXALIPLATIN |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 |
| ATC code | L01XA |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-10-19 |
| Actual discontinuation date | 2018-10-19 |
| Remaining supply date | 2018-10-19 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2018-10-24 | French | Compare |
| v8 | 2018-10-24 | English | Compare |
| v7 | 2018-08-29 | French | Compare |
| v6 | 2018-08-29 | English | Compare |
| v5 | 2018-08-29 | French | Compare |
| v4 | 2018-08-29 | English | Compare |
| v3 | 2018-08-07 | French | Compare |
| v2 | 2018-08-07 | English | Compare |
| v1 | 2018-08-07 | English | Compare |
Showing 1 to 9 of 9